Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Oncotarget
|
February 9, 2017
Characterizing the last holdouts
Erin L Stewart, Ming-Sound Tsao
Handbook of Clinical Neurology
|
November 29, 2018
Sports neurology as a multidisciplinary field
Erin L Stewart, Scott A Anderson, Vernon B Williams
Translational Lung Cancer Research
|
March 26, 2015
Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review
Erin L Stewart, Samuel Zhixing Tan, Geoffrey Liu, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 15, 2020
Predictors of participant nonadherence in lung cancer screening programs: a systematic review and meta-analysis
Andrew C L Lam, Reenika Aggarwal, Serina Cheung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 19, 2022
Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model
Nadeem Moghal, Quan Li, Erin L Stewart, et al.
Clinical Lung Cancer
|
May 12, 2020
Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib
Sabine Schmid, Erin L Stewart, Sebastiao N Martins-Filho, et al.
Cancers
|
June 26, 2026
A Multimodal Artificial Intelligence Model to Guide Use of Whole-Pelvic Radiation Therapy in Patients with Localized Prostate Cancer: Exploratory Analysis of RTOG 9413
Mutlay Sayan, Huei-Chung Huang, Erin L Stewart, et al.
Science Translational Medicine
|
November 17, 2021
Assessing therapy response in patient-derived xenografts
Janosch Ortmann, Ladislav Rampášek, Elijah Tai, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 25, 2020
EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft models
Sebastiao N Martins-Filho, Jessica Weiss, Nhu-An Pham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2015
Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma
Erin L Stewart, Celine Mascaux, Nhu-An Pham, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Oncotarget
|
February 9, 2017
Characterizing the last holdouts
Erin L Stewart, Ming-Sound Tsao
Handbook of Clinical Neurology
|
November 29, 2018
Sports neurology as a multidisciplinary field
Erin L Stewart, Scott A Anderson, Vernon B Williams
Translational Lung Cancer Research
|
March 26, 2015
Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review
Erin L Stewart, Samuel Zhixing Tan, Geoffrey Liu, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 15, 2020
Predictors of participant nonadherence in lung cancer screening programs: a systematic review and meta-analysis
Andrew C L Lam, Reenika Aggarwal, Serina Cheung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 19, 2022
Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model
Nadeem Moghal, Quan Li, Erin L Stewart, et al.
Clinical Lung Cancer
|
May 12, 2020
Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib
Sabine Schmid, Erin L Stewart, Sebastiao N Martins-Filho, et al.
Cancers
|
June 26, 2026
A Multimodal Artificial Intelligence Model to Guide Use of Whole-Pelvic Radiation Therapy in Patients with Localized Prostate Cancer: Exploratory Analysis of RTOG 9413
Mutlay Sayan, Huei-Chung Huang, Erin L Stewart, et al.
Science Translational Medicine
|
November 17, 2021
Assessing therapy response in patient-derived xenografts
Janosch Ortmann, Ladislav Rampášek, Elijah Tai, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 25, 2020
EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft models
Sebastiao N Martins-Filho, Jessica Weiss, Nhu-An Pham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2015
Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma
Erin L Stewart, Celine Mascaux, Nhu-An Pham, et al.
Page
of 1